Saturday, January 12, 2013

Circulating Tumor Cell ( CTC ) market info

Below is a compilation of publicly available market info from various sources

Market Potential

A recent market report was published by Transparency Market Research ( titled "Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market - Global Scenario, Trends, Size, Growth and Industry Analysis, 2011 - 2018." Globally, CTCs and CSCs Market is estimated to reach USD 7.9 billion by 2018. The global market for cancer diagnostics based on Circulating Cancer Cells (CTCs) was estimated at USD 1.0 billion in 2011. Majority of the share is most likely held by Veridex LLC (Johnson and Johnson)

CTC market estimates used by other CTC companies
Market size
Creatv Microtech [1]
USD 600
10-20 Bln
20-30 mln tests in US.
1 test/year/patient
Ikonisys [2]
USD 400
35 Bln
Total Addressable Market: 4 Bln (monitoring), 35 Bln (early detection)
Parsortix (listed) [3]
4 Bln
Est. 20,000 separations from single pharma site p.a. 25 Mln p.a. early stage rev.
Rheoblast [4]
5.2 Bln
10 Mln US patients= 25 M tests/year. 2-3 tests/yr/pat.
6000 clinical labs in US (2-3% growth)
1400 cancer treatment centers in US (6-7% growth)
150 biomarker companies and research labs

Figure 4:  source [4]

CTC application segment
Therapy monitoring
Prognostic functions hold 58.28% of the total CTC Technologies market

Figure 5 is the estimated market share by a CTC company, Silicon Biosystems, which provides solution for cell sorting.

Figure 6 is the estimated market share by a CTC company, Filtini, which provides microfilter based CTC isolation device

The demand for cellular analysis will also expand significantly during the next five years. This sector was worth $10 million in 2010 and is expected to increase at a 95.4% compound annual growth rate (CAGR) to reach $296 million in 2015.

List of all active commercial circulating tumor cell ( CTC ) technologies is here

other documents of interest

No comments:

Post a Comment